Frontiers

Bringing the Best to Ohio State Pelotonia13

​BRINGING THE BEST TO OHIO STATE Money raised by Pelotonia riders and donors has been committed to recruiting and retaining some of the brightest minds in cancer research to Ohio State. Among those recently ...[Read more]
Published: May-14-13 | 0  Comment | 0  Link to this post

Registration open 2013

​ REGISTRATION OPEN FOR PELOTONIA 13 Anyone wanting to participate in Pelotonia 13 as a rider, virtual rider or volunteer should visit http://pelotonia.org/register/ and sign up for this year’s tour, to be held Aug. 9-11. Riders may choose from ...[Read more]
Published: May-14-13 | 1  Comment | 0  Link to this post

Up Front Winter 2013

Understanding the Molecular Mechanisms of Malignancy is Key to Cancer Care A tenet of Ohio State's cancer program is that there is no such thing as a routine cancer. Likewise, there is nothing routine about the science-based care we offer. ...[Read more]
Published: Feb-13-13 | 1  Comment | 0  Link to this post

Frontline Winter 2013

Recurrent Ovarian Cancer: WE MUST DO BETTER Ovarian cancer is a relatively rare disease, but it is the most lethal of all gynecologic malignancies and the fifth most common cause of cancer death in women. About 22,300 women were expected to be ...[Read more]
Published: Feb-13-13 | 1  Comment | 0  Link to this post

Break Through Winter 2013

HEDGEHOG HUNTING A Possible Therapy for Tamoxifen-Resistant Breast Cancer BHUVANESWARI RAMASWAMY, MD, a medical oncologist specializing in breast cancer at the OSUCCC - JamesSARMILA MAJUMDER, PHD, a research assistant professor in ...[Read more]
Published: Feb-13-13 | 0  Comment | 0  Link to this post

Of Note Winter 2013

AWARDS AND HONORS JOHN C.BYRD, MD, was featured in Clinical Cancer Advances 2012: ASCO’s Annual Report on Progress Against Cancer. Published by the American Society of Clinical Oncology, the annual report i ...[Read more]
Published: Feb-13-13 | 1  Comment | 0  Link to this post

About-Face for Chronic Leukemia

Origin of CLL and the Molecular Mechanism of Ibrutinib Multipotent hematopoietic stem cells (HSC) give rise to healthy B lymphocytes. Recent evidence suggests that genetic changes at the HSC level lead to monoclonal B cells that the ...[Read more]
Published: Feb-13-13 | 0  Comment | 0  Link to this post

A Singular Focus on Lung Cancer

DAVID CARBONE, MD, PHD, lung cancer specialist for the OSUCCC - James A Singular Focus On Lung Cancer David Carbone joins Ohio State's lung cancer team to organize a thoracic oncology center By BOB HECKER David Carbone, MD, PhD, ...[Read more]
Published: Feb-13-13 | 0  Comment | 0  Link to this post

<< Previous    Next >>